<SEC-DOCUMENT>0001606498-20-000066.txt : 20210203
<SEC-HEADER>0001606498-20-000066.hdr.sgml : 20210203
<ACCEPTANCE-DATETIME>20201218102322
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001606498-20-000066
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20201218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Avanos Medical, Inc.
		CENTRAL INDEX KEY:			0001606498
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				464987888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004
		BUSINESS PHONE:		678-425-9273

	MAIL ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halyard Health, Inc.
		DATE OF NAME CHANGE:	20140424
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="if81c669615f34eef888f4b2aa426513a_32"></div><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><img alt="avanoslogo1.jpg" src="avanoslogo1.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avanos Medical, Inc.<br>5405 Windward Parkway<br>Suite 100 South<br>Alpharetta, GA 30004</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 18, 2020</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIA EMAIL AND REGULAR MAIL</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Michael Fay</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities and Exchange Commission</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Division of Corporate Finance</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Office of Life Sciences</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 F Street NE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 205479</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Re&#58;&#160;&#160;&#160;&#160;Avanos Medical, Inc.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-K for the Fiscal Year Ended December 31, 2019</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Filed February 27, 2020</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">File No. 001-36440</font></div><div style="margin-top:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Mr. Fay&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This letter is in response to the December 7, 2020 letter from the staff (the &#8220;Staff&#8221;) of the Securities Exchange Commission (the &#8220;Commission&#8221;).</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For convenience, the Staff&#8217;s comments are copied below, followed by the Company&#8217;s response.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Staff Comment No. 1</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We note that your forum selection provision in Article X, Section 1 of your Second Amended and Restated Certificate of Incorporation identifies a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware) as the exclusive forum for certain litigation, including any &#8220;derivative action.&#8221; In future filings, please disclose whether this provision applies to actions arising under the Securities Act or Exchange Act. If so, please also state that there is uncertainty as to whether a court would enforce such provision. If the provision applies to Securities Act claims, please also state that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. In that regard, we note that Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</font></div><div style="margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Response&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company respectfully acknowledges the Staff&#8217;s comment and will include disclosure as a Risk Factor in its Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, and other applicable filings with the Commission, in substantially the form shown below&#58;</font></div><div style="margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware (or if that court does not have jurisdiction, the U.S. District Court for the District of Delaware) as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors or officers.</font></div><div style="margin-top:9pt;padding-left:36pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Michael Fay</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities and Exchange Commission</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 2</font></div></div><div style="margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless we consent to the selection of an alternative forum, our certificate of incorporation provides that the Court of Chancery of the State of Delaware (or, if that court shall not have jurisdiction, the U.S. District Court for the District of Delaware) shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors or officers or our stockholders, creditors or other constituents, (iii) any action asserting a claim against us or any of our directors or officers arising pursuant to any provision of the DGCL or our certificate of incorporation or by-laws (in each case, as they may be amended from time to time), or (iv) any action asserting a claim against us or any of our directors or officers or employees governed by the internal affairs doctrine. We believe this provision benefits us by providing increased consistency in the application of Delaware law by chancellors particularly experienced in resolving corporate disputes, efficient administration of cases on a more expedited schedule relative to other forums and protection against the burdens of multi-forum litigation. Notwithstanding the foregoing, the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act, the Securities Act or any claim for which the federal courts have exclusive jurisdiction.</font></div><div style="margin-top:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors or officers, which may discourage such lawsuits against us and our directors or officers. Alternatively, if a court were to find the choice of forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our financial condition and results of operations.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Staff Comment No. 2</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Item 15. Exhibits</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future filings, please ensure that all documents that must be filed as exhibits are either filed or incorporated by reference. Refer to Item 601 of Regulation S-K. For example, we note no plans of acquisition, reorganization, arrangement or succession, articles of incorporation, bylaws, instruments defining the rights of security holders, including indentures, or material contracts are identified as filed or incorporated by reference.</font></div><div style="margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Response&#58;</font></div><div style="margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company respectfully acknowledges the Staff&#8217;s comment, and in future filings, we will ensure that all documents that must be filed according to Item 601 of Regulation S-K will either be filed or incorporated by reference in Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, and other applicable filings with the Commission.</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you have any further questions or comments regarding the Company&#8217;s response to the Staff&#8217;s comments, please contact me at (470) 448-5578 or via email at renato.negro&#64;avanos.com.</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avanos Medical, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Renato Negro</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renato Negro<br>Vice President and Controller</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>avanoslogo1.jpg
<DESCRIPTION>AVANOS LOGO
<TEXT>
begin 644 avanoslogo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[@ .061O8F4 9      !_^$ AD5X:68
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M 1$  A$! Q$!_\0 'P   @(" P$! 0            H)"P<( P0%!@(!_\0
M6!    8! P(# P0)#0L- 0   0(#! 4&!P 1"!()(1,*,4$442(5%S)"M-26
M5W=X.6%QL7*2LB,S);75%EA2<[,D='6V-Q@X&H'!8H)#4\/C-(0UAD@9_\0
M&0$  P$! 0                ,$ @$%_\0 )!$  @,  @(# 0$! 0$
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MQGJQ9H9?X:5A)ABAU).$%-AZ#IF\0';6;^$S5/+17>?_ -;>Y5_;/SE^%/\
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M)$U#@R]KIP- "O\ ZGOBP.0^-.,^4<!&F<6' EK-5[:X;IJ*+#CC(YTDBJ*
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M RK&2<;-1S"8AY!C+1,HS;2$9*1CM-_'2+!X0%$5T%TC'26353,!B'(80$!
M0';5 D[V@"OX]25RO/FSFLQP/!2BKFD\8*V2MN6J2RGP*N3+@1"0FEN@1\LQ
MV[8&30Q@#P,D<N_MU%O:7'T595A21F]LGBTXYB\WL"X259KNJJ_MS>U9&41
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MS5JA>DF'4=1$IA\T6,H4IG#%0WM+U)B(J)*;6]^]6R;KTLBOEU"5%B[Z<_\
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M9OQ:U<+F.(LW!D8ZR-$2B7I(5)86#DI0-N(J*FV\!'5/KVY0C:OR.$ZJ$!H
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MA1N0 (,VF$^:CJ:QX8H?GGBGR0XP3RU<S]A;(6+)!)Q\*DO:*\LW@Y%7;?\
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E\# _Y\;?X74M.2E\%F'@G_5/2?\ ,;#_  1->@B-\F7-=.'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
